SEC Form 4 · accession 0001209191-17-046389
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel D Colella
Director · 10% Owner
Period of report
Jun 22, 2017
Accepted (ET)
Jul 27, 2017 · 9:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $20.16 | Jun 22, 2017 | A | 12,500 | A | — | Jun 21, 2027 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.